Although activation of NF-κB, STAT3 and/or the PI3K/AKT pathway in B cell neoplasms has been described [23-25], the mechanism by which these pathways contribute to the development of BCLs remains unclear, as do the circumstances under which this occurs. The gene discussed is NFKB1; the disease is B-cell neoplasm.